FIP was once universally fatal, but antiviral treatments now offer genuine cure rates over 85%, transforming welfare outcomes for affected cats.
Before antiviral treatments, cats diagnosed with FIP experienced a terminal illness with weeks to months of progressive debilitation including fluid accumulation, weight loss, neurological signs, and ultimately organ failure. Treatment with GS-441524 transforms this prognosis, with most treated cats achieving complete clinical recovery and resuming normal quality of life. The welfare revolution is incomplete, however - treatment costs of $3,000-$8,000 USD mean many cats are euthanized for financial reasons despite a curable condition, creating a profound equity issue in companion animal welfare.